Abstract
Corticosteroids are thought to cause bone loss by a combination of inhibitory effects on bone formation and enhanced bone resorption, with the inhibitory effects on bone formation appearing to be most important.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Hall GM, Daniels M, Doyle DV et al. (1994) The effect of hormone replacement therapy on bone mass in rheumatoid arthritis treated with and without steroids. Arthritis and Rheumatism 37: 1499–1505.
Mulder H, Struys A. (1994) Intermittent cyclical etidronate in the prevention of corticosteroid induced bone loss. Br J Rheumatology 33: 348–350
Reid ℝ, Wattie DJ, Evans MC, Stapleton JP. (1996) Testosterone therapy in glucocorticoid treated men. Arch Intern Med 156: 1173–77.
Sambrook PN, Birmingham J, Kelly PJ et al. (1993) Prevention of corticosteroid osteoporosis; a comparison of calcium, calcitriol and calcitonin. N Engl J Med 328: 1747–52.
Sambrook PN, Jones G. (1995) Corticosteroid osteoporosis. Br J Rheumatology 34: 8–12.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag London Limited
About this chapter
Cite this chapter
Naganathan, V., Sambrook, P.N. (1998). Corticosteroid-induced Osteoporosis. In: Geusens, P. (eds) Osteoporosis in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-4471-3382-7_23
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3382-7_23
Publisher Name: Springer, London
Print ISBN: 978-3-540-76223-2
Online ISBN: 978-1-4471-3382-7
eBook Packages: Springer Book Archive